Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial. - Wikidata - wikimedia - TriplyDB

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

http://www.wikidata.org/entity/Q51902123

about

Intraoperative floppy iris syndrome: pathophysiology, prevention, and treatment Finasteride to prevent prostate cancer: should all men or only a high-risk subgroup be treated?Finasteride does not increase the risk of high-grade prostate cancer: a bias-adjusted modeling approach.Chemoprevention of prostate cancer.Persistent sexual dysfunction and depression in finasteride users for male pattern hair loss: a serious concern or red herring?Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome Use of 5-alpha-reductase inhibitors for prostate cancer chemoprevention: American Society of Clinical Oncology/American Urological Association 2008 Clinical Practice Guideline Factor analysis of the modified Sexual Adjustment Questionnaire-Male Health-related quality-of-life findings for the prostate cancer prevention trial Non-steroidal anti-inflammatory drug (NSAID) use is not associated with erectile dysfunction risk: results from the Prostate Cancer Prevention Trial.Finasteride in the treatment of patients with benign prostatic hyperplasia: a review Enhancing nurse contributions to SWOG clinical trials.Persistent erectile dysfunction in men exposed to the 5α-reductase inhibitors, finasteride, or dutasteride.Prostate cancer prevention: concepts and clinical recommendations.Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis.Long-term Consequences of Finasteride vs Placebo in the Prostate Cancer Prevention Trial.Finasteride-its impact on sexual function and prostate cancer.Finasteride and sexual side effects.Treatment of male androgenetic alopecia with topical products containing Serenoa repens extract.Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia.Drug Treatment for Androgenetic Alopecia: First Italian Questionnaire Survey on What Dermatologists Think about Finasteride.

P2860

Q33623451-9F5B32E4-D5D9-4E28-A1D7-269D506B0797 Q33710942-6005FE3B-2FC4-4B72-A4D0-02F8BEFBBD6C Q33750580-83BBA455-670A-496D-8701-74322ED22FFC Q34186757-B372B25B-0E5F-4AE0-89C0-B77D90629E54 Q34457965-191B5E25-5458-4BF0-B0E4-4A7E5DA69B3E Q34552026-DBD83DA6-1E21-4094-9B66-DE506A4642F3 Q34604979-EEE3B77A-2C87-4CFC-88D2-01A862245A91 Q36330986-CE2CD149-9AE5-45A0-B08E-E7EABDBADEE9 Q36486786-78BBCFF7-2CC0-4CC4-9047-1EE10ABB77BC Q36781932-985FF278-0D10-4170-8FF4-10D645C6E32C Q37261063-B6E3ACD9-0E81-4D72-ADD9-D3AEE4E41750 Q37651986-13E63C93-7EF4-493E-8AE7-33D8AB0833C8 Q37694089-5AA52DB6-60A0-475A-A177-DDC52EFF8131 Q37766754-306642B5-5672-4617-8C5C-93B5757351C7 Q38814349-B206C735-8BC6-49A9-A589-E761D7A2F62A Q39168087-E7EAA991-BBE3-441D-A713-9E2A74D8F887 Q39681594-5DF10613-A834-498E-A030-47195B92E59F Q42134250-D43B08E6-E70D-4263-9730-F6134F098109 Q48183066-6D8C2DB6-4384-47EE-9950-AA96A2A8945C Q49039304-62BB49E7-FB63-4F89-96E2-C4136A9D419D Q55354556-9FDEC4D6-4440-4A20-954A-95070E72F8F9

P2860

Longitudinal analysis of sexual function reported by men in the Prostate Cancer Prevention Trial.

http://www.wikidata.org/entity/Q51902123

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@en

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@nl

type

label

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@en

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@nl

prefLabel

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@en

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@nl

P1433

Q51902123-5F97C603-C2A9-440F-9F4D-FD964A8D3B85

P1476

Q51902123-DEFDC298-F5FF-4233-93ED-BF45AFB785AE

P2093

Q51902123-18C4166D-299A-41F2-8340-904230DC7E6D

Q51902123-21C8F0C9-E212-4E95-8B6D-7BC23DDA0CE1

Q51902123-22A88FA4-57D3-4552-AA17-F21DA11A7366

Q51902123-5475E4EA-3542-4B9E-9B52-5F7A722F3F25

Q51902123-A738F174-615F-42DB-A0F4-A83D9CE7F8AC

Q51902123-CB166A1E-221E-4637-998F-36AD3B14D9B4

Q51902123-CB7CD83B-1607-4CA8-98B5-01FA6BBA0D7B

Q51902123-EE9E68C8-D446-4B87-8465-9DD88F824C26

Q51902123-F026586E-AD35-4540-8642-B711645FA855

Q51902123-F440033B-85EB-4081-96E6-DAE97F13C6F4

P304

Q51902123-E7223578-9C50-4FF4-830A-09A281FED503

P31

Q51902123-A06E78DD-7E6E-4791-9A7D-88CF592D5DF7

P356

Q51902123-D24BAA5D-74B9-4066-863B-12F044D9BD98

P407

Q51902123-78A07C2B-E23D-497E-96C5-B8F0608D26D0

P433

Q51902123-CF524539-007E-4638-AA5B-1D6813CDF2CD

P478

Q51902123-230B8656-86FF-440F-B2B6-CD4330E70479

P50

Q51902123-6C973A85-FC03-4A3A-8A28-3870D982AAA0

Q51902123-DA1A4938-36B7-4F34-833D-03A390C15E3C

P577

Q51902123-A23D396F-D2B8-4461-9108-F874ED47A7CB

P698

Q51902123-E582263E-D1A3-4041-A082-CB927E01BE8C

P356

P1433

Journal of the National Cancer Institute

P1476

Longitudinal analysis of sexua ...... state Cancer Prevention Trial.

@en

P2093

Carol M Moinpour

http://www.w3.org/2001/XMLSchema#string

Charles A Coltman

http://www.w3.org/2001/XMLSchema#string

Connie Langley

http://www.w3.org/2001/XMLSchema#string

Donald L Patrick

http://www.w3.org/2001/XMLSchema#string

Gary W Donaldson

http://www.w3.org/2001/XMLSchema#string

Ian M Thompson

http://www.w3.org/2001/XMLSchema#string

John E Ware

http://www.w3.org/2001/XMLSchema#string

Patricia A Ganz

http://www.w3.org/2001/XMLSchema#string

Sally A Shumaker

http://www.w3.org/2001/XMLSchema#string

Scott M Lippman

http://www.w3.org/2001/XMLSchema#string

P304

1025-1035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/JNCI/DJM023

http://www.w3.org/2001/XMLSchema#string

P407

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

99

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-06-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17596576

http://www.w3.org/2001/XMLSchema#string